Vimarsana
Biggest News Aggregation in the World

Page 23 - Inducement Plan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inducement Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inducement Plan Today - Breaking & Trending Today

Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer - Vimarsana News

Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer

BETHESDA, Md., April 12, 2023 -- Gain Therapeutics, Inc. , a biotechnology company leading the discovery and development of allosteric small molecule therapies, today announced the appointment of... | June 19, 2023

Sonder Holdings Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Sonder Holdings Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Sonder Holdings Inc. today announced that on April 10, 2023, the Compensation Committee of Sonder’s Board of Directors made equity inducement grants of stock options exercisable for an... | April 11, 2023

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Seres Therapeutics, Inc. , a leading microbiome therapeutics company, today announced that on April 5, 2023, the Compensation and Talent Committee of Seres’ board of directors granted... | April 7, 2023

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Vimarsana News

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc....

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Vimarsana News

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., April 6, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc. Inducement Plan,... | June 20, 2023